Name | Eptaplatin |
---|---|
Synonyms |
[propanedioato(2-)-κO,O]platinum - [(4R,5R)-2-(propan-2-yl)-1,3-dioxolane-4,5-diyl]dimethanamine (1:1)
(SP-4-2)-[(4R,5R)-2-Isopropyl-1,3-dioxolane-4,5 Platinum(2+) malonate [(4R,5R)-2-isopropyl-1,3-dioxolane-4,5-diyl]dimethanamine (1:1:1) platinum, [propanedioato(2-)-κO,κO]-, compd. with (4R,5R)-2-(1-methylethyl)-1,3-dioxolane-4,5-dimethanamine (1:1) EPTAPLATIN,SUNPLA SKI 2053R [Malonato(2-)-κO,O]platinum - [(4R,5R)-2-isopropyl-1,3-dioxolane-4,5-diyl]dimethanamine (1:1) sunpla EPOXYPROGESTERONE Heptaplatin cis-[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane](malonate)platinum(II) (SP-4-2)-[(4R,5R)-2-ISOPROPYL-1,3-DIOXOLANE-4,5-BIS(METHANAMINE)-N,N'][PROPANEDIOATO(2-)-O,O']PLATINUM |
Description | Heptaplatin (SKI 2053R) is a platinum derivative with anticancer activity against various cancer cell lines, including cisplatin-resistant tumor cell lines. SKI-2053R is active in the research of gastric adenocarcinoma and has favorable toxicity profiles[1]. |
---|---|
Related Catalog | |
References |
Boiling Point | 261.5ºC at 760 mmHg |
---|---|
Melting Point | 43-49ºC |
Molecular Formula | C11H20N2O6Pt |
Molecular Weight | 471.36 |
Flash Point | 114ºC |
Exact Mass | 471.096924 |
PSA | 123.10000 |
LogP | 0.45950 |
Vapour Pressure | 0.0115mmHg at 25°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Codes | Xn |
---|